These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2974739)

  • 1. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.
    Cook NS; Weir SW; Danzeisen MC
    Br J Pharmacol; 1988 Nov; 95(3):741-52. PubMed ID: 2974739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cromakalim inhibits contractions of the rat isolated mesenteric bed induced by noradrenaline but not caffeine in Ca(2+)-free medium: evidence for interference with receptor-mediated Ca2+ mobilization.
    Quast U; Baumlin Y
    Eur J Pharmacol; 1991 Aug; 200(2-3):239-49. PubMed ID: 1782988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacitative Ca2+ entry associated with alpha1-adrenoceptors in rat aorta.
    Noguera MA; Ivorra MD; Chuliá S; D'Ocon P
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):83-9. PubMed ID: 9228194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cromakalim on contractions in rabbit isolated renal artery in the presence and absence of extracellular Ca2+.
    Wilson C; Cooper SM
    Br J Pharmacol; 1989 Dec; 98(4):1303-11. PubMed ID: 2575415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta.
    Bray KM; Weston AH; Duty S; Newgreen DT; Longmore J; Edwards G; Brown TJ
    Br J Pharmacol; 1991 Feb; 102(2):337-44. PubMed ID: 2015418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle.
    Chiu PJ; Tetzloff G; Ahn HS; Sybertz EJ
    Eur J Pharmacol; 1988 Oct; 155(3):229-37. PubMed ID: 3234486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of K+ channel blockers on the relaxant action of dihydralazine, cromakalim and nitroprusside in isolated rabbit femoral arteries.
    Thirstrup S; Nielsen-Kudsk JE
    Eur J Pharmacol; 1992 May; 215(2-3):177-83. PubMed ID: 1396985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glibenclamide on cytosolic calcium concentrations and on contraction of the rabbit aorta.
    Yoshitake K; Hirano K; Kanaide H
    Br J Pharmacol; 1991 Jan; 102(1):113-8. PubMed ID: 1904292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cromakalim on KCl-, noradrenaline- and angiotensin II-induced contractions in the rat pulmonary artery.
    Savineau JP; Marthan R
    Pulm Pharmacol; 1993 Mar; 6(1):41-8. PubMed ID: 8477154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
    Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the K+ channel blocker tedisamil on 86Rb efflux induced by cromakalim, high potassium and noradrenaline, and on mechanical tension in rabbit isolated vascular smooth muscle.
    Kreye VA; Pfründer D; Theiss U
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):238-43. PubMed ID: 1570026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution.
    Duty S; Weston AH
    Br J Pharmacol; 1992 Dec; 107(4):1198-204. PubMed ID: 1467840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
    Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
    Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies on the interactions of beta2-adrenoceptor agonists, methylxanthines, Ca2+-channel blockers, K+-channel openers and other airway smooth muscle relaxants in isolated guinea-pig trachea.
    Thirstrup S; Nielsen-Kudsk F; Dahl R
    Eur J Pharmacol; 1997 May; 326(2-3):191-200. PubMed ID: 9196272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional study on the effects of nifedipine, cromakalim, and the absence of extracellular Ca2+ on alpha 1-adrenoceptor-mediated excitation-contraction coupling in isolated rat portal vein: comparison with depolarization-mediated excitation-contraction coupling.
    Schwietert R; Wilhelm D; Wilffert B; van Zwieten PA
    J Cardiovasc Pharmacol; 1993 May; 21(5):739-48. PubMed ID: 7685443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine.
    Kawahara J; Izumi H; Okada Y; Izawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):460-5. PubMed ID: 8897449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
    Quast U; Villhauer EB
    Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cromakalim inhibits multiple mechanisms of smooth muscle activation with similar stereoselectivity.
    Kühberger E; Kukovetz WR; Groschner K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):947-54. PubMed ID: 7687721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.